STK38 and metabolic dysfunction-associated steatotic liver disease: Thus, our study suggests that STK38 is a critical node of the lipogenic/immune axis and provides a potential therapeutic target to ameliorate inflammation and insulin resistance in lean and nonlean NAFLD.